Optiderm (Lauromacrogol 400, Urea)

Lauromacrogol 400 and Urea, the active ingredients in Optiderm, are a sclerosing agent and keratolytic presented as a topical formulation for cutaneous use. The combination works to induce sclerosis of abnormal vascular structures while softening and hydrating thickened skin, making it suitable for treating vascular lesions and hyperkeratotic dermatoses in adult patients.

GNH USA supplies Optiderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this dermatological preparation across global markets.

Optiderm, containing Lauromacrogol and Urea, is employed in dermatology for conditions involving abnormal vascular growth and excessive skin keratinisation.

- Venous malformations: reduces size and discoloration by inducing endothelial sclerosis, improving cosmetic appearance. - Superficial hemangiomas: promotes regression of proliferative vascular lesions through targeted sclerosing action. - Hyperkeratotic skin disorders (e.g., ichthyosis, keratoderma): softens thickened stratum corneum and enhances hydration, facilitating desquamation.

Topical application of Optiderm may be associated with local skin reactions.

Common Side Effects: - Erythema: mild redness at the application site. - Pruritus: transient itching or irritation. - Burning sensation: temporary discomfort during use. - Dryness: reduced skin moisture leading to flaking. - Scaling: superficial skin shedding. - Mild edema: slight swelling of the treated area.

Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling, or anaphylaxis requiring medical attention. - Ulceration: breakdown of skin leading to open sores. - Necrosis: tissue death at the site of application, especially with excessive use. - Contact dermatitis: persistent inflammation and rash. - Systemic hypotension: rare drop in blood pressure if significant absorption occurs.

When using Optiderm, consider the following safety measures.

- Apply only to intact skin: avoid broken or inflamed areas to reduce irritation. - Avoid eyes and mucous membranes: contact may cause severe discomfort. - Do not use on infected lesions: risk of spreading infection. - Monitor for allergic reactions: discontinue use if signs of hypersensitivity appear. - Consult healthcare professional during pregnancy or lactation: limited safety data are available. - Store at room temperature: keep in the original container, protect from moisture and light.

Optiderm may interact with other topical agents; awareness of potential interactions helps minimize adverse effects.

Major Interactions (Avoid): - Concurrent use with other sclerosing agents (e.g., polidocanol): may increase risk of excessive tissue damage. - Combination with high‑strength keratolytics (e.g., 10% salicylic acid): can cause severe irritation or chemical burns.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may alter drug absorption and potency. - Use under occlusive dressings: can enhance systemic uptake, increasing side‑effect risk. - Interaction with other moisturizers containing alcohol: may increase skin dryness.